Atomoxetine treatment of attention-deficit/hyperactivity disorder.

about

Lobeline Effects on Cognitive Performance in Adult ADHD.Benign clinical course following atomoxetine overdose.Prevalence of patients using drugs metabolized by cytochrome P450 2D6 in different populations: a cross-sectional study.

P2860

Q33774323-6F39171C-7572-4D7C-8642-DF7213F77E47 Q45283300-309D4C0D-9429-41FF-B060-3CFC7C2D56B4 Q51906214-C6D22ED6-007A-44B7-81BA-195F97A4E40C

P2860

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

Item

http://www.wikidata.org/entity/Q35638049

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@ast

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@en

type

Item

label

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@ast

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@en

prefLabel

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@ast

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@en

P1476

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

@en

P2093

Abby L Guest

http://www.w3.org/2001/XMLSchema#string

Lea S Eiland

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder.

Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder.

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics.

Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

P304

86-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1D144

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14742801

http://www.w3.org/2001/XMLSchema#string

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

about

P2860

P2860

Atomoxetine treatment of attention-deficit/hyperactivity disorder.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698